170 related articles for article (PubMed ID: 36789162)
1. Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms.
Thompson-Peach CAL; Foßelteder J; Reinisch A; Thomas D
Bio Protoc; 2023 Jan; 13(2):e4592. PubMed ID: 36789162
[TBL] [Abstract][Full Text] [Related]
2. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells.
Williams JL; Pipia GG; Datta NS; Long MW
Blood; 1998 Jun; 91(11):4118-26. PubMed ID: 9596657
[TBL] [Abstract][Full Text] [Related]
4. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.
Broudy VC; Lin NL; Kaushansky K
Blood; 1995 Apr; 85(7):1719-26. PubMed ID: 7535585
[TBL] [Abstract][Full Text] [Related]
6. JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling.
Zhang Y; Lin CHS; Kaushansky K; Zhan H
Stem Cells; 2018 Nov; 36(11):1676-1684. PubMed ID: 30005133
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.
Elliot MA; Yoon SY; Kao P; Li CY; Tefferi A
Eur J Haematol; 2002 Mar; 68(3):175-9. PubMed ID: 12068799
[TBL] [Abstract][Full Text] [Related]
8. Producing megakaryocytes from a human peripheral blood source.
Ivetic N; Nazi I; Karim N; Clare R; Smith JW; Moore JC; Hope KJ; Kelton JG; Arnold DM
Transfusion; 2016 May; 56(5):1066-74. PubMed ID: 26756864
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
[TBL] [Abstract][Full Text] [Related]
10. CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.
Kim SY; Im K; Park SN; Kwon J; Kim JA; Lee DS
Am J Clin Pathol; 2015 May; 143(5):635-44. PubMed ID: 25873496
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin- primitive progenitor cells.
Young JC; Bruno E; Luens KM; Wu S; Backer M; Murray LJ
Blood; 1996 Sep; 88(5):1619-31. PubMed ID: 8781417
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells.
Nagata Y; Nagahisa H; Aida Y; Okutomi K; Nagasawa T; Todokoro K
J Biol Chem; 1995 Aug; 270(34):19673-5. PubMed ID: 7649975
[TBL] [Abstract][Full Text] [Related]
13. JAK2
Zhan H; Ma Y; Lin CH; Kaushansky K
Leukemia; 2016 Dec; 30(12):2332-2341. PubMed ID: 27133820
[TBL] [Abstract][Full Text] [Related]
14. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand.
Banu N; Wang JF; Deng B; Groopman JE; Avraham H
Blood; 1995 Aug; 86(4):1331-8. PubMed ID: 7632939
[TBL] [Abstract][Full Text] [Related]
15. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK).
Hodohara K; Fujii N; Yamamoto N; Kaushansky K
Blood; 2000 Feb; 95(3):769-75. PubMed ID: 10648384
[TBL] [Abstract][Full Text] [Related]
16. [In vitro expansion of cord blood megakaryocyte progenitor].
Feng Y; Xiao ZJ; Xu SC; Lu SH; Liu B; Liu JH; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):199-204. PubMed ID: 15960266
[TBL] [Abstract][Full Text] [Related]
17. In vitro megakaryocyte differentiation and proplatelet formation in Ph-negative classical myeloproliferative neoplasms: distinct patterns in the different clinical phenotypes.
Balduini A; Badalucco S; Pugliano MT; Baev D; De Silvestri A; Cattaneo M; Rosti V; Barosi G
PLoS One; 2011; 6(6):e21015. PubMed ID: 21698292
[TBL] [Abstract][Full Text] [Related]
18. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
[TBL] [Abstract][Full Text] [Related]
19. Flt3/Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34+ cells.
Sigurjónsson OE; Gudmundsson KO; Haraldsdóttir V; Rafnar T; Gudmundsson S
J Hematother Stem Cell Res; 2002 Apr; 11(2):389-400. PubMed ID: 11983110
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity of megakaryocyte progenitors to thrombopoietin in essential thrombocythemia.
Kawasaki H; Nakano T; Kohdera U; Kobayashi Y
Am J Hematol; 2001 Nov; 68(3):194-7. PubMed ID: 11754402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]